小结
定义
病史和体格检查
关键诊断因素
- 存在的危险因素
- 皮损生长数周至数月
- 球型,高出皮面的丘疹
- 皮损表面的小黑点
其他诊断因素
- 卫星灶
- 指或甲皱皮损
- 面部皮损
- 裂隙
- 角化过度
- 灰白色或浅棕色
- 丝状丘疹伴尖锐的尖状物
危险因素
- 水浸泡
- 涉及处理肉类和鱼类的职业。
- 咬甲癖
- 年龄小于35岁
- 免疫功能低下
诊断性检查
首要检查
- 无初始检查
需考虑的检查
- 皮肤活检
- 免疫过氧化物酶染色
- 皮肤培养
治疗流程
寻常疣:免疫健全
寻常疣:免疫低下
丝状疣
撰稿人
作者
Angela Yen Moore, MD
Director
Arlington Center of Dermatology
Primary Investigator
Arlington Research Center
Arlington
Clinical Assistant Professor
Baylor University Medical Center
Dallas
Clinical Assistant Professor
University of Texas Medical Branch
Galveston
TX
利益声明
Dr. Moore receives funds as an advisory board member (A), consultant (C), clinical study investigator (I), and speaker (SP) – for Abbvie (I,SP), Almirall (C,I,SP), Arcutis (I), Biofrontera (C,I), Boehringer Ingelheim (I), Bristol-Myers Squibb (C,I), Dermavant (I), DS Biopharma (I), Eli Lilly (I), EpiHealth (A), Evolus (A), Galderma (I), Incyte (I), Janssen (I), Leo (A,SP), Mayne Pharma (C,I), Nimbus (I), Novartis (I), Parexel (I), Pfizer (I,SP), UCB (I), Verrica (I), Vyne (I,SP).
鸣谢
Dr Angela Yen Moore would like to gratefully acknowledge Dr Leonid Izikson, the previous contributor to this topic. LI declares that he has no competing interests.
同行评议者
Brenda L. Pellicane, MD
Dermatologist
Wayne State University School of Medicine
Department of Dermatology
Detroit
MI
利益声明
BLP declares that she has no competing interests.
David Cassarino, MD, PhD
Assistant Professor
Department of Pathology and Laboratory Medicine
University of California
Los Angeles
CA
利益声明
DC declares that he has no competing interests.
Jashin J. Wu, MD
Chief Dermatology Resident
University of California
Irvine
CA
利益声明
JJW declares that he has no competing interests.
Sam Gibbs, FRCP
Consultant Dermatologist
Dermatology Department
The Great Western Hospital
Swindon
UK
利益声明
SG declares that he has no competing interests.
鉴别诊断
- 扁平疣
- 掌跖疣
- 脂溢性角化病
更多 鉴别诊断指南
- HIV 感染和暴露儿童机会性感染的预防和治疗指南
- 成人和青少年 HIV 感染者机会性感染的预防和治疗指南
更多 指南患者教育信息
疣(常见)
人乳头瘤病毒(human papillomavirus, HPV)疫苗
更多 患者教育信息- 登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明